Jenburkt Pharmaceuticals Ltd — Updates, 18-07-2025: Company Update

Jenburkt Pharmaceuticals shareholders at their 40th Annual General Meeting have approved the appointment of M/s. Nilesh Shah & Associates as the company's Secretarial Auditors. This important step ensures ongoing regulatory compliance and corporate governance. The appointment is for a new five-year term, effective from the current AGM until the 45th AGM in 2030. Notably, M/s. Nilesh Shah & Associates is a well-regarded firm with over 22 years of experience, having already served Jenburkt as Secretarial Auditors for more than a decade, ensuring continuity in this crucial oversight role.